PDS Biotechnology Corp Earnings

The next earnings date for PDS Biotechnology Corp is November 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of PDS Biotechnology Corp Earnings

Report Date	Estimated Earnings Per Share
11/12/2025	$-0.21

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

PDS Biotechnology Corp Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/13/2025	---	$-0.21	4.55%
05/13/2025	Before Market	$-0.21	14.88%
03/25/2025	Before Market	---	---
11/12/2024	Before Market	$-0.29	-3.57%
08/13/2024	Before Market	$-0.23	32.35%
05/15/2024	Before Market	$-0.30	18.92%
03/27/2024	Before Market	$-0.35	20.45%
11/14/2023	Before Market	$-0.35	22.22%
08/14/2023	Before Market	$-0.37	-5.71%
05/15/2023	Before Market	$-0.32	-3.23%
03/28/2023	Before Market	$-0.67	-131.03%
11/14/2022	Before Market	$-0.26	7.14%
08/08/2022	Before Market	$-0.20	28.57%
05/11/2022	Before Market	$-0.32	-45.45%
03/31/2022	Before Market	$-0.22	8.33%
11/10/2021	Before Market	$-0.24	-20.00%
08/12/2021	Before Market	$-0.03	82.35%
05/13/2021	Before Market	$-0.14	26.32%
03/18/2021	Before Market	$-0.18	5.26%
11/11/2020	After Market	$-0.23	-64.29%
08/13/2020	Before Market	$-0.19	17.39%
05/13/2020	Before Market	$-0.39	-160.00%
03/27/2020	After Market	$-0.84	8.70%
11/07/2019	Before Market	$-1.10	-34.15%
08/01/2019	Before Market	$-0.75	---
05/14/2019	Before Market	$1.47	---
02/21/2019	Before Market	$-0.10	96.15%
11/01/2018	Before Market	$-2.29	-748.15%
08/01/2018	Before Market	$-8.20	22.05%
05/01/2018	Before Market	$-13.40	-27.38%
03/01/2018	Before Market	$-9	-4.41%
11/01/2017	Before Market	$-7.40	22.51%
08/01/2017	Before Market	$-8.80	-0.69%
05/03/2017	Before Market	$-8.40	0.59%
03/02/2017	Before Market	$-6.60	20.58%
11/01/2016	Before Market	$-7.40	7.15%
08/03/2016	Before Market	$-6.60	11.88%
05/03/2016	Before Market	$-6.40	6.02%
03/08/2016	Before Market	$-6	4.76%
11/06/2015	Before Market	$-141.60	-345.28%

More About PDS Biotechnology Corp

Website

https://www.pdsbiotech.com

Country

USA

Full Time Employees

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company's lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. Further, the company provides PDS0202, a novel investigational influenza vaccine that protects against the strains predicted to be prevalent in an upcoming flu season. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.

“PDS Biotechnology Corp Earnings” Can Refer to the PDS Biotechnology Corp Earnings Date

Some people say “PDS Biotechnology Corp earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my PDS Biotechnology Corp position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning PDS Biotechnology Corp Stock on the Earnings Date

If you own PDS Biotechnology Corp stock (PDSB) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for PDS Biotechnology Corp might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading PDS Biotechnology Corp shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More PDS Biotechnology Corp Earnings

You can contact us any time if you would like to ask questions about PDS Biotechnology Corp earnings or anything else related to the stock market.